ArticleJournal of orthopaedic surgery and research2025
METTL3 promotes chondrocyte injury in osteoarthritis by increasing CTSB expression.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteoarthritis (OA) is one of the most frequent joint diseases and its incidence is increasing. However, its pathogenesis remains poorly understood. The study aims to analyze the role and mechanism of methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit (METTL3) in OA.
methodsHuman chondrocytes (CHON-001 and C28/I2) were stimulated using interleukin-1β (IL-1β) to mimic OA-like cell injury. mRNA expression levels were measured by quantitative real-time polymerase chain reaction. Protein expression was detected by Western blotting. Cell Counting Kit-8 assay was used to detect cell viability. Flow cytometry analysis and TUNEL assay were performed to analyze cell apoptosis. Enzyme-linked immunosorbent assays were used to measure the levels of TNF-α and IL-6. Cellular ROS Assay kit was used to detect ROS level. Lipid peroxidation MDA assay kit was utilized to detect MDA level. Fe
resultsMETTL3 and CTSB expression were upregulated in human osteoarthritic cartilage in comparison with healthy cartilage tissues. Treatment with IL-1β up-regulated the expression of both METTL3 and CTSB in human chondrocytes. Knockdown of METTL3 or CTSB attenuated the pro-apoptotic, pro-inflammatory, oxidative, and ferroptotic effects induced by IL-1β in these cells. In addition, METTL3 upregulated CTSB expression by regulating its m6A methylation. Moreover, the protective effects of METTL3 silencing against IL-1β-induced injury were dependent on the downregulation of CTSB.
conclusionMETTL3 promoted chondrocyte injury by upregulating CTSB expression in OA, thereby highlighting METTL3-CTSB axis as a promising target for therapeutic intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.